SCHEMBL25351971

SCHEMBL25351971

O=C(O)c1cccc(-c2cn(Cc3ccc(-c4nnc(C(F)F)o4)cc3F)nn2)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.48
▸ PTGES2 Q9H7Z7 1/20 0.48
▸ UCHL1 P09936 1/20 0.48
▸ UCHL3 P15374 1/20 0.48
▸ UCHL5 Q9Y5K5 1/20 0.48
▸ HDAC1 Q13547 14/20 0.46
▸ PTGES O14684 1/20 0.45
▸ HDAC6 Q9UBN7 2/20 0.44
▸ HDAC3 O15379 1/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ HDAC7 Q8WUI4 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43
▸ HDAC10 Q969S8 1/20 0.43
▸ HDAC11 Q96DB2 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43
▸ HDAC9 Q9UKV0 1/20 0.43
▸ HDAC5 Q9UQL6 1/20 0.43
▸ MYC P01106 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31535158 1.00 ALOX5 (0.48) ALOX5PTGES2UCHL1UCHL3UCHL5
SCHEMBL25351083 0.92 ALOX5 (0.48) ALOX5PTGES2HDAC1PTGESHDAC6
SCHEMBL30409440 0.89 HDAC1 (0.48) ALOX5PTGES2HDAC1HDAC6
SCHEMBL24215834 0.89 HDAC1 (0.48) ALOX5PTGES2HDAC1HDAC6
SCHEMBL25350937 0.88 HDAC6 (0.44) UCHL5HDAC1HDAC6HDAC3HDAC2
SCHEMBL30410054 0.87 HDAC1 (0.42) HDAC1HDAC6
SCHEMBL24215788 0.87 HDAC1 (0.42) HDAC1HDAC6
SCHEMBL30425196 0.87 UCHL5 (0.56) ALOX5PTGES2UCHL1UCHL3UCHL5
SCHEMBL25215900 0.87 UCHL5 (0.56) ALOX5PTGES2UCHL1UCHL3UCHL5
SCHEMBL24216081 0.86 TEK (0.47) UCHL5HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 ALOX5 4373/4885PTGES2 4622/4885UCHL1 1703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback